TLIS logo

Talis Biomedical (TLIS) Cash From Investing

TLIS Annual CFI

-$486.00 K
+$1.13 M+69.91%

31 December 2023

TLIS Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TLIS Quarterly CFI

$84.00 K
+$54.00 K+180.00%

30 June 2024

TLIS Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TLIS TTM CFI

$137.00 K
+$569.00 K+131.71%

30 June 2024

TLIS TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TLIS Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+69.9%+117.3%+109.7%
3 y3 years+94.1%+271.4%+108.5%
5 y5 years+8.8%+271.4%+108.5%

TLIS Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+83.0%-9.7%+108.5%at high+104.8%
5 y5-yearat high+94.1%-9.7%+101.5%at high+101.5%
alltimeall timeat high+94.1%-9.7%+101.5%at high+101.5%

Talis Biomedical Cash From Investing History

DateAnnualQuarterlyTTM
June 2024
-
$84.00 K(+180.0%)
$137.00 K(-131.7%)
Mar 2024
-
$30.00 K(-67.7%)
-$432.00 K(-11.1%)
Dec 2023
-$486.00 K(-69.9%)
$93.00 K(-232.9%)
-$486.00 K(-22.6%)
Sept 2023
-
-$70.00 K(-85.6%)
-$628.00 K(-55.7%)
June 2023
-
-$485.00 K(+1920.8%)
-$1.42 M(+25.3%)
Mar 2023
-
-$24.00 K(-51.0%)
-$1.13 M(-29.9%)
Dec 2022
-$1.61 M(-43.6%)
-$49.00 K(-94.3%)
-$1.61 M(-36.7%)
Sept 2022
-
-$860.00 K(+332.2%)
-$2.55 M(+4.1%)
June 2022
-
-$199.00 K(-60.7%)
-$2.45 M(-8.3%)
Mar 2022
-
-$507.00 K(-48.6%)
-$2.67 M(-6.7%)
DateAnnualQuarterlyTTM
Dec 2021
-$2.87 M(-65.1%)
-$987.00 K(+30.0%)
-$2.87 M(-33.1%)
Sept 2021
-
-$759.00 K(+79.9%)
-$4.29 M(-52.3%)
June 2021
-
-$422.00 K(-39.5%)
-$8.98 M(+2.3%)
Mar 2021
-
-$698.00 K(-71.0%)
-$8.78 M(+7.1%)
Dec 2020
-$8.20 M(+1318.9%)
-$2.41 M(-55.9%)
-$8.20 M(+41.5%)
Sept 2020
-
-$5.46 M(+2403.7%)
-$5.79 M(+1619.6%)
June 2020
-
-$218.00 K(+83.2%)
-$337.00 K(+183.2%)
Mar 2020
-
-$119.00 K
-$119.00 K
Dec 2019
-$578.00 K(+8.4%)
-
-
Dec 2018
-$533.00 K
-
-

FAQ

  • What is Talis Biomedical annual cash flow from investing activities?
  • What is the all time high annual CFI for Talis Biomedical?
  • What is Talis Biomedical annual CFI year-on-year change?
  • What is Talis Biomedical quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Talis Biomedical?
  • What is Talis Biomedical quarterly CFI year-on-year change?
  • What is Talis Biomedical TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Talis Biomedical?
  • What is Talis Biomedical TTM CFI year-on-year change?

What is Talis Biomedical annual cash flow from investing activities?

The current annual CFI of TLIS is -$486.00 K

What is the all time high annual CFI for Talis Biomedical?

Talis Biomedical all-time high annual cash flow from investing activities is -$486.00 K

What is Talis Biomedical annual CFI year-on-year change?

Over the past year, TLIS annual cash flow from investing activities has changed by +$1.13 M (+69.91%)

What is Talis Biomedical quarterly cash flow from investing activities?

The current quarterly CFI of TLIS is $84.00 K

What is the all time high quarterly CFI for Talis Biomedical?

Talis Biomedical all-time high quarterly cash flow from investing activities is $93.00 K

What is Talis Biomedical quarterly CFI year-on-year change?

Over the past year, TLIS quarterly cash flow from investing activities has changed by +$569.00 K (+117.32%)

What is Talis Biomedical TTM cash flow from investing activities?

The current TTM CFI of TLIS is $137.00 K

What is the all time high TTM CFI for Talis Biomedical?

Talis Biomedical all-time high TTM cash flow from investing activities is $137.00 K

What is Talis Biomedical TTM CFI year-on-year change?

Over the past year, TLIS TTM cash flow from investing activities has changed by +$1.55 M (+109.66%)